Novo Nordisk A-S (Class B)

7. aug 2024, 10:13 UTC

Novo Nordisk's Wegovy Sales Disappoint -- 2nd Update

7. aug 2024, 06:58 UTC

Wegovy Maker Novo Nordisk Lifts Sales Guidance as Weight-Loss Drug Demand Continues to Surge -- Update

7. aug 2024, 06:10 UTC

Wegovy Maker Novo Nordisk Lifts Sales Guidance as Weight-Loss Drug Demand Continues to Surge

3. sept 2024, 11:09 UTC

Novo Nordisk's Says Ozempic Shortage Deteriorates. Why It's Good News For Eli Lilly. -- Barrons.com

27. aug 2024, 05:30 UTC

Weight-Loss Drugs Get More Good News. For Investors, It's Still Too Soon to Celebrate. -- Barrons.com

14. aug 2024, 12:01 UTC

Novo Nordisk's Pricing and Pipeline to Remain Hot Topics -- Market Talk

9. aug 2024, 11:30 UTC

Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race -- Heard on the Street -- WSJ

9. aug 2024, 07:30 UTC

Novo Nordisk Share Pullback Represents Great Opportunity -- Market Talk

8. aug 2024, 15:44 UTC

Eli Lilly Shows We Haven't Hit Peak Obesity Yet -- WSJ

8. aug 2024, 11:36 UTC

Novo Nordisk's Share-Price Weakness Provides an Opportunity -- Market Talk

8. aug 2024, 07:16 UTC

Novo Nordisk's Share-Price Drop Provides Buying Opportunity -- Market Talk

7. aug 2024, 20:30 UTC

Eli Lilly Reports Earnings Thursday Amid a Stock Slump. Here's What to Expect. -- Barrons.com

7. aug 2024, 16:39 UTC

Novo Nordisk's Wegovy Sales Disappoint -- Update

7. aug 2024, 15:30 UTC

Novo Nordisk's Wegovy Sales Disappoint -- WSJ

7. aug 2024, 14:22 UTC

It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ

7. aug 2024, 12:28 UTC

Novo Nordisk's Core Products Disappoint -- Market Talk

7. aug 2024, 12:04 UTC

Novo Nordisk Execs Were Speaking on a Call After 2Q Earnings

7. aug 2024, 11:34 UTC

Novo Nordisk US Head: As Wegovy Volumes Go Up, Prices Will Come Down

7. aug 2024, 11:34 UTC

Novo Nordisk CEO: When You Move Into New Sales Channels it Comes With a Discount

7. aug 2024, 11:34 UTC

Novo Nordisk CEO: Wegovy Now Covered in 20 States Through Medicaid

7. aug 2024, 11:05 UTC

Novo Nordisk Delivers Messy Quarter as Wegovy Misses The Mark -- Market Talk

7. aug 2024, 10:55 UTC

Stock Market Madness Highlights This Problem for -2-

7. aug 2024, 10:55 UTC

Stock Market Madness Highlights This Problem for Novo Nordisk and Super Micro. And 5 Other Things to Know Today. -- Barrons.com

7. aug 2024, 09:07 UTC

Stocks to Watch Wednesday: Super Micro, Rivian, Airbnb -- WSJ

7. aug 2024, 08:55 UTC

These Stocks Are Moving the Most Today: Super Micro, Lumen, Airbnb, Rivian, Fortinet, Upstart, Disney, and More -- Barrons.com

7. aug 2024, 07:32 UTC

Novo Nordisk Wegovy Sales Disappoint -- Market Talk

7. aug 2024, 05:45 UTC

Novo Nordisk Declares Interim Dividend of DKK3.50

7. aug 2024, 05:44 UTC

Novo Nordisk 2Q Gross Margin 84.9% Vs 85.5%, Op Margin 38.1% Vs 44.0%

7. aug 2024, 05:40 UTC

Novo Nordisk 2Q Wegovy Drug Sales DKK11.66B Vs DKK7.52B

7. aug 2024, 05:38 UTC

Novo Nordisk: Sales Growth Has Resulted in Periodic Supply Constraints, Related Drug Shortage Notifications